Economic evaluation of a pneumococcal vaccine in a high-risk population

@inproceedings{Agarwal2013EconomicEO,
  title={Economic evaluation of a pneumococcal vaccine in a high-risk population},
  author={Sushil Kumar Agarwal},
  year={2013}
}
This economic evaluation study was performed to estimate the cost effectiveness of a 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in a high-risk population. Herd immunity has developed as a result of pneumococcal serotypes used in 7-valent pneumococcal conjugate vaccine in infants. Assuming a similar effect with 13-valent pneumococcal conjugate vaccine would mean a … 

Similar Papers

Topics from this paper.